Postoperative Analgesia With Local Infiltration After Hip Fracture Of Intertrochanteric Type

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01119209

Enrollment

Registered

2010-05-07

Start date

2008-02-29

Completion date

2011-01-31

Last updated

2011-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fracture of Intertrochanteric Type

Keywords

Hip fracture, intertrochanteric

Brief summary

Reducing pain is an essential factor for early mobilization after osteosynthesis of intertrochanteric fractures. Systemic opioids have side effects that might obstruct mobilization and induce delirium and nausea. The investigators hypothesized that wound infiltration results in reduction in systemic opioid usage and pain relief without side effects.

Interventions

DRUGRopivacaine

Approved by the Danish Medicines Agency

DRUGSaline

Approved by the Danish Medicines Agency

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Intertrochanteric hip fracture * Fracture due to low energy trauma * Ability to understand danish and give informed consent * Ability to walk before trauma * Indication for osteosynthesis •≥ 8 in OMC (Orientation-Memory-Concentration) test with a possible maximum of 28 points * Informed consent

Exclusion criteria

* Drug or medical abuse * Drug intolerance * Pathological fractures * Inflammatory arthritis * Patient included in the study with the contralateral hip

Design outcomes

Primary

Measure	Time frame
Consumption of opioids	5 days postoperatively

Secondary

Measure	Time frame
Pain	5 days postoperatively

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026